Lacking Evidence to Recommend Neoadjuvant Chemotherapy and Definitive Radiotherapy in Muscle-Invasive Bladder Cancer : In response to: Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions published by Di Maria Jiang et al. Current Oncology Reports 2020, https://doi.org/10.1007/s11912-020-0880-5

Curr Oncol Rep. 2021 Jan 20;23(2):18. doi: 10.1007/s11912-020-01012-8.

Abstract

We comment on the paper of Di Maria Jiang et al. published in Current Oncology Reports 2020, https://doi.org/10.1007/s11912-020-0880-5 . We disagree on a major recommendation of the authors because of lacking evidence. This response is considered to be important for readers of Current Oncology Reports.

Keywords: Bladder cancer; Neoadjuvant chemotherapy; Trimodality treatment.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review
  • Comment

MeSH terms

  • Chemotherapy, Adjuvant
  • Cystectomy
  • Humans
  • Muscles
  • Neoadjuvant Therapy
  • Urinary Bladder Neoplasms* / drug therapy